Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo

Jun-o Deguchi1, Masanori Aikawa, Ching-Hsuan Tung

  • 1Donald W. Reynolds Cardiovascular Clinical Research Center, Harvard Medical School, Boston, Massachusetts, USA.

Circulation
|June 28, 2006
PubMed
Abstract

Insights

Optical molecular imaging effectively detects matrix metalloproteinase (MMP) activity in atherosclerotic plaques. This approach visualizes gelatinase action in vivo, aiding in assessing cardiovascular risk and therapeutic efficacy.

Area of Science:

  • Biomedical Imaging
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Matrix metalloproteinases (MMPs) play a role in atherosclerotic plaque remodeling and thrombotic events.
  • Inflamed atherosclerotic plaques are characterized by MMP activity.

Purpose of the Study:

  • To evaluate optical molecular imaging using a near-infrared fluorescence (NIRF) probe for detecting MMP enzymatic action in atherosclerosis.
  • To assess the feasibility of noninvasive in vivo imaging of MMP activity.

Main Methods:

  • Apolipoprotein E-deficient (apoE-/-) mice on a high-cholesterol diet were used to model atherosclerosis.
  • A NIRF substrate for gelatinases (MMP-2/MMP-9) was administered, and NIRF signals were detected ex vivo and in vivo.
  • In situ zymography and immunohistochemistry were used to confirm gelatinase activity and MMP presence.

Main Results:

  • Atherosclerotic aortas in apoE-/- mice showed intense NIRF signals, indicating gelatinase activity, unlike control mice.
  • NIRF signal localization correlated with macrophage accumulation and MMP-2/MMP-9 expression.
  • In vivo fluorescence molecular tomography confirmed the detection of gelatinase action in atherosclerotic aortas.

Conclusions:

  • Noninvasive in vivo imaging of MMP enzymatic action in atherosclerosis is feasible.
  • This imaging approach can help gauge inflammatory foci and assess cardiovascular risk.
  • The method holds potential for evaluating the efficacy of therapeutic interventions in atherosclerosis.